Saaimatul Huq
Researcher
Also affiliated: Winthrop Rockefeller Foundation (2024); Saitama University (2009–2010)
Formerly Arkansas Affiliated with UAMS through 2024; recent publications list Winthrop Rockefeller Foundation.
Unknown Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Saaimatul Huq's research focuses on investigating potential therapeutic targets and diagnostic markers in various cancers, with a particular emphasis on pancreatic and rectal cancers. Huq has published work exploring the enhancement of radiosensitivity in these cancers through the inhibition of Cyclin-dependent kinase 1 and targeting of SETD2. Additionally, Huq's research includes an immunoinformatic investigation into Rift Valley fever virus proteins, identifying possible epitopes for vaccine development. Huq collaborates with researchers at the University of Arkansas for Medical Sciences, including Adam R. Wolfe and Lokesh Akana, with whom Huq has co-authored multiple publications. Huq's scholarly output includes 5 publications with an h-index of 2 and 21 total citations.
Metrics
- h-index: 2
- Publications: 5
- Citations: 21
Selected Publications
-
CRISPR-mediated Correction of Oncogenic AS-NMD in Splicing Factor Mutant Cancer (2026)
-
Abstract A033: Targeting SETD2 in Combination with Radiotherapy in Rectal Cancer (2025)
-
Enhancing Rectal Cancer Radiosensitivity and Gut Protection through Methionine Restriction (2025)
-
Abstract A011: Enhanced Radiosensitivity of Pancreatic Cancer Achieved through Inhibition of Cyclin-Dependent Kinase 1 (2024)
-
Enhanced radiosensitivity of pancreatic cancer achieved through inhibition of Cyclin-dependent kinase 1 (2024)
-
An immunoinformatic investigation on Rift Valley fever virus protein reveals possible epitopes for vaccines (2024)
Collaboration Network
Top Collaborators
- Enhanced radiosensitivity of pancreatic cancer achieved through inhibition of Cyclin-dependent kinase 1
- Abstract A011: Enhanced Radiosensitivity of Pancreatic Cancer Achieved through Inhibition of Cyclin-Dependent Kinase 1
- Enhancing Rectal Cancer Radiosensitivity and Gut Protection through Methionine Restriction
- Abstract A033: Targeting SETD2 in Combination with Radiotherapy in Rectal Cancer
- Enhanced radiosensitivity of pancreatic cancer achieved through inhibition of Cyclin-dependent kinase 1
- Abstract A011: Enhanced Radiosensitivity of Pancreatic Cancer Achieved through Inhibition of Cyclin-Dependent Kinase 1
- Enhancing Rectal Cancer Radiosensitivity and Gut Protection through Methionine Restriction
- Abstract A033: Targeting SETD2 in Combination with Radiotherapy in Rectal Cancer
- Abstract A011: Enhanced Radiosensitivity of Pancreatic Cancer Achieved through Inhibition of Cyclin-Dependent Kinase 1
- Enhancing Rectal Cancer Radiosensitivity and Gut Protection through Methionine Restriction
- Abstract A033: Targeting SETD2 in Combination with Radiotherapy in Rectal Cancer
- Enhanced radiosensitivity of pancreatic cancer achieved through inhibition of Cyclin-dependent kinase 1
- Abstract A011: Enhanced Radiosensitivity of Pancreatic Cancer Achieved through Inhibition of Cyclin-Dependent Kinase 1
- Enhanced radiosensitivity of pancreatic cancer achieved through inhibition of Cyclin-dependent kinase 1
- Abstract A011: Enhanced Radiosensitivity of Pancreatic Cancer Achieved through Inhibition of Cyclin-Dependent Kinase 1
- An immunoinformatic investigation on Rift Valley fever virus protein reveals possible epitopes for vaccines
- An immunoinformatic investigation on Rift Valley fever virus protein reveals possible epitopes for vaccines
- An immunoinformatic investigation on Rift Valley fever virus protein reveals possible epitopes for vaccines
- An immunoinformatic investigation on Rift Valley fever virus protein reveals possible epitopes for vaccines
- Enhanced radiosensitivity of pancreatic cancer achieved through inhibition of Cyclin-dependent kinase 1
- Enhanced radiosensitivity of pancreatic cancer achieved through inhibition of Cyclin-dependent kinase 1
- Enhancing Rectal Cancer Radiosensitivity and Gut Protection through Methionine Restriction
- Enhancing Rectal Cancer Radiosensitivity and Gut Protection through Methionine Restriction
- Enhancing Rectal Cancer Radiosensitivity and Gut Protection through Methionine Restriction
- Enhancing Rectal Cancer Radiosensitivity and Gut Protection through Methionine Restriction
Similar Researchers
Based on overlapping research topics